Clinical Trial Update: Efficacy of TPI ASM8 During a 14-Day Allergen Challenge [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy of TPI ASM8 during a 14-day allergen challenge in asthma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• TPI ASM8

Snippet

Sponsor: Syntara | Conditions: Asthma | Phase 2 | Status: COMPLETED